Humanigen Expands Partnership with Catalent Biologics to Manufacture Investigational COVID-19 Therapeutic Candidate Lenzilumab Read more
Novartis launches first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19 Read more
Orchard Therapeutics Announces Global License Agreements for Stable Cell Line Technology from GSK Read more
BioAegis Therapeutics Receives Approval to Proceed with Phase 2 Trial of its Gelsolin COVID-19 Treatment Read more
Sanofi and MD Anderson announce strategic collaboration to accelerate oncology research and development Read more